New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Modular Medical, Inc.

MODD

Healthcare Medical Devices

EPS
n/m
Free cash flow
n/m

Quarter to September 2026, against a year earlier

1.91 0.09 +4.95%
Market cap
$17.7M
P/E
n/m
Fwd P/E
—
Dividend yield
—
F-score
n/a
ROIC
−263.1%
Net debt / EBITDA
0.3×
Payout ratio
—

Capital & Financial Ratios $m

Size
Market Cap 18
Revenue ttm —
Net income ttm (27)
Free cash flow ttm (28)
Net debt Q (5)
Valuation
P/E n/m
Forward P/E e —
Price / sales n/m
Forward P/S e Powerpack
Price / FCF n/m
Price / book 1.3
Financial health
Current ratio Q 4.5 (at or above 1.5: strong)
Debt / equity Q n/m
Interest coverage Q —
Growth
Revenue growth e —
EPS growth e +38.5% (at or above 15%: strong)
EPS growth e +18.8% (at or above 15%: strong)
EPS growth, 5 yrs e —
Insiders
Owned by insiders 0.0%

Green and red mark values outside typical ranges; (Q) is the latest quarter; e marks analysts’ estimates; n/m is not meaningful, as a P/E on a loss. How we judge →

Compound annual growth

10y 5y 3y
Sales — — —
Cash Flow — 0.00% 0.00%
Earnings — 0.00% 0.00%
Book Value — 0.00% 36.67%

Valuation

P/B against its own 10 years 6.13%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Analysts’ price targets Wall Street, collected weekly

Analyst price targets

Analysts’ consensus Wall Street average, updated each weekday

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance

Ten-year view Analyst estimates Powerpack
Group Line 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 TTM Sep ’26 Trend 10 yrs 2027e 2028e 2029e Next 3/yr
Income, $m
Income, $m Revenue — — — — — — — — — — — — 35 — — —
Gross margin, % — 0.00 0.00 0.00 0.00 0.00 0.00 — — — 0.00 0.0 pt
EBT — (1) (3) (5) (7) (19) (14) (17) (19) (28) (27) +60.0%
EBT margin, % — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.0 pt
Net income — (1) (3) (5) (7) (19) (14) (17) (19) (28) (27) +60.0%
Per share, $
Per share, $ Revenue — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 n/m
Earnings — (1.48) (4.60) (9.01) (35.67) (82.28) (34.40) (23.42) (15.31) (12.36) (6.49) +30.3%
Cash flow — (1.78) (3.27) (6.88) (28.57) (45.26) (27.32) (18.72) (12.75) (10.40) (3.18) +24.7%
Capex — (0.03) (0.14) (0.44) (0.53) (0.24) (4.06) (2.28) (2.02) (1.72) (0.38) +63.0%
Free cash flow — (1.82) (3.41) (7.32) (29.10) (45.50) (31.39) (21.00) (14.77) (12.12) (3.56) +26.8%
Book value — 9.73 11.72 4.84 (6.17) 38.98 12.60 15.48 13.85 5.67 1.44 (6.5%)
Shares, m — 0 1 1 0 0 0 1 1 2 4 +22.7%
Valuation, ×
Valuation, × P/E — — — — — — — — — — 0 —
P/S — — — — — — — — — — 0 —
P/B — — — — — — — — — — 0 —
EV/Sales — — — — — — — — — — 0 —
EV/FCF — — — — — — — — — — 0 —
Cash, $m
Cash, $m Operating cash flow — (1) (2) (4) (6) (10) (11) (14) (16) (24) (25) +53.0%
Capex — 0 0 0 0 0 (2) (2) (2) (4) (3) +100.1%
Free cash flow — (1) (2) (4) (6) (10) (13) (16) (18) (28) (28) +55.6%
Balance, $m
Balance, $m Working capital — 4 6 3 (2) 8 3 8 12 6 5 +3.5%
Net debt — (4) (7) (3) (1) (9) (4) (9) (13) (7) (5) +6.2%
Shareholders’ equity — 4 6 3 (1) 9 5 12 17 13 11 +14.7%
Returns, %
Returns, % ROA — (12.00) (46.23) (101.24) (241.63) (308.12) (162.41) (165.97) (115.69) (168.27) (212.69) (156.3) pt
ROIC — (1,867.15) 0.00 0.00 0.00 0.00 (679.23) (475.71) (298.97) (286.27) (263.11) +1,580.9 pt
ROE — (31.96) (47.06) (113.79) (920.35) (492.82) (199.51) (210.34) (131.58) (188.05) (270.84) (156.1) pt
People
People Employees — — 6 13 20 25 38 40 54 51 — +35.8%
Revenue/emp, $m — — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 — n/m
Negative figures in brackets.
estimates

All 10 years →

Fundamentals updated 18 Nov 2026

Modular Medical, Inc. vs peers in Medical Devices (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
NNOX Nano-X Imaging Ltd. $20.6M — (loss-making) — (loss-making) +36.71% (above 0%: growing) n/m −21.37% (below 0%: shrinking) (1,050.87%) (1,334.91%) Compare
MODD Modular Medical, Inc. $17.7M — (loss-making) — — n/m −2.99% (below 0%: shrinking) 0.00% 0.00%
CTSO Cytosorbents Corporation $17.5M — (loss-making) — (loss-making) +0.17% (above 0%: growing) n/m +64.90% (above 0%: growing) 73.18% (27.39%) Compare
CVRX CVRx, Inc. $17.2M — (loss-making) — (loss-making) −5.84% (below 0%: shrinking) n/m −9.91% (below 0%: shrinking) 86.74% (94.31%) Compare
PMI Flag Ship Acquisition Corp $17.1M — (loss-making) — (loss-making) −81.72% (below 0%: shrinking) n/m +69.36% (above 0%: growing) 43.78% (968.20%) Compare
ALUR Allurion Technologies, Inc. $16.7M — (loss-making) — (loss-making) −47.19% (below 0%: shrinking) n/m +65.98% (above 0%: growing) 41.70% (126.60%) Compare
SNWV Sanuwave Health Inc. $14.7M 3.3× — (loss-making) −23.88% (below 0%: shrinking) n/m −119.02% (below 0%: shrinking) 77.27% (12.50%) Compare
RBOT Vicarious Surgical Inc. $14.3M — (loss-making) — — n/m +47.33% (above 0%: growing) 0.00% 0.00% Compare
PETV PetVivo Holdings, Inc. $12.9M — (loss-making) — (loss-making) −29.84% (below 0%: shrinking) n/m +56.35% (above 0%: growing) 92.15% (907.42%) Compare
Median of peers $16.9M — — −23.88% — +51.84% 58.48% (110.46%)

All 148 Medical Devices stocks →

Pay and ownership Proxy statement filed 1 October 2026

Chief executive’s pay

Year Total pay Actually paid $100 invested
2026 47.00k 17.06k (90.49)

Ownership

Directors and executive officers, together 2.25%
AWM Investment Company 9.99%
Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s shares at the start of the earliest year shown was worth at each year’s end. Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

Modular Medical, Inc. (MODD) Latest News

What happened

  1. Deal Modular Medical secured agreements with all three of the largest U.S. PBMs, which collectively cover more than 182 million people.
19 more headlines
All MODD news, as stories →
stockrow.com/MODD · Data as of Nov 18, 2026 · For information only; not investment advice. · © 2026 stockrow.com